Results 171 to 180 of about 16,305 (230)

Association of systemic inflammatory biomarkers with prostate cancer risk: a population-based (NHANES) and clinical validation study. [PDF]

Front Endocrinol (Lausanne)
Huang G, Xiao K, Lin S, Lu X.
europepmc   +1 more source

The role of microrna-346 in prostate cancer progression: Clinical significance and biomarker potential. [PDF]

J Med Biochem
Wang L, Wang Y, Tian L, Wang Z, Liu X, Cheng G.   +5 more
europepmc   +1 more source

Integration of circulating biomarkers and clinical factors: construction and validation of a prediction model for lung cancer metastasis. [PDF]

BMC Pulm Med
Qi W, Li Z, Xu J, Wang T.
europepmc   +1 more source

Xanthogranulomatous prostatitis masquerading as prostate cancer: a case report and literature review. [PDF]

BMC Geriatr
Jiang Y, Zhang J, Shen J.
europepmc   +1 more source

Modeling Financial Time Series Volatility with Markov Switching Models [PDF]

Michal Pietrzak, Monika Kosko
core  

The combination of prostate health index and multiparametric magnetic resonance imaging in prostate cancer diagnosis: efficacy analysis in different PSA ranges and its clinical decision-guiding value. [PDF]

World J Urol
Pan JF, Chen YZ, Wang SY, Zhao ZY, Ren DW, Su R, Jia XL, Jiang JH, Ma Q.   +8 more
europepmc   +1 more source

CNS penetrant TEAD1,2,4 inhibitor MSC-4070 derived from phenotypic screening hit optimization. [PDF]

RSC Med Chem
Heinrich T, Petersson C, Gunera J, Gambardella A, Schwarz D, Garg S, Schilke H, Weitzel T, Kolb C, Anlauf U, Reither V, Rettig C, Opelt B, Delp A, Wildner N, Sousa PMF, Freire F, Bandeiras TM, Wienke D.   +18 more
europepmc   +1 more source

Lupane Triterpenes with Antileukemia Activity from <i>Maytenus quadrangulata</i>. [PDF]

ACS Omega
Quintão SVM, de Aguilar MG, Souza LC, Freitas TR, Jardim MECDS, de Souza LBE, Sabino AP, Duarte LP, F de Sousa G.   +8 more
europepmc   +1 more source